Chitosan Engineered PAMAM Dendrimers as Nanoconstructs for the Enhanced Anti-Cancer Potential and Improved In vivo Brain Pharmacokinetics of Temozolomide

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Pharmaceutical Research

• Publication date

  2018-01-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s11095-017-2324-yPMID 29294212
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Surface-coated PLA nanoparticles loaded with temozolomide for improved brain deposition and potential treatment of gliomas: development, characterization and in vivo studies

  2016cited by this paper
• Brain Targeting of Temozolomide via the Intranasal Route Using Lipid-Based Nanoparticles: Brain Pharmacokinetic and Scintigraphic Analyses.

  2016cited by this paper
• Brain Targeting of a Water Insoluble Antipsychotic Drug Haloperidol via the Intranasal Route Using PAMAM Dendrimer.

  2015cited by this paper
• Dual targeted polymeric nanoparticles based on tumor endothelium and tumor cells for enhanced antitumor drug delivery.

  2014cited by this paper
• Multivalent Polymers for Drug Delivery and Imaging: The Challenges of Conjugation

  2014cited by this paper
• Dendrimer as nanocarrier for drug delivery

  2014cited by this paper
• Preparation and electrochemical properties of LiFePO4/C nanoparticles using different organic carbon sources

  2013cited by this paper
• Transferrin-tailored solid lipid nanoparticles as vectors for site-specific delivery of temozolomide to brain

  2013cited by this paper
• Performance evaluation of PAMAM dendrimer based simvastatin formulations.

  2011cited by this paper
• Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles.

  2011cited by this paper
• Development of Polysorbate 80/Phospholipid mixed micellar formation for docetaxel and assessment of its in vivo distribution in animal models

  2011cited by this paper
• Hybrids of nonviral vectors for gene delivery.

  2010cited by this paper
• Kinetic modeling on drug release from controlled drug delivery systems.

  2010cited by this paper
• Gene expression profiling predicts response to temozolomide in malignant gliomas.

  2010cited by this paper
• Determination of the degree of N-acetylation for chitin and chitosan by various NMR spectroscopy techniques: A review

  2010cited by this paper
• Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

  2010cited by this paper
• Pre-clinical and behavioural toxicity profile of PAMAM dendrimers in mice

  2010cited by this paper
• New strategies to deliver anticancer drugs to brain tumors

  2009cited by this paper
• Recent progress towards development of effective systemic chemotherapy for the treatment of malignant brain tumors

  2009cited by this paper
• Folate and folate-PEG-PAMAM dendrimers: synthesis, characterization, and targeted anticancer drug delivery potential in tumor bearing mice.

  2008cited by this paper
• Gadofullerene MRI contrast agents.

  2008cited by this paper
• New therapeutic approach for brain tumors: Intranasal delivery of telomerase inhibitor GRN163.

  2008cited by this paper
• Targeted gadolinium-loaded dendrimer nanoparticles for tumor-specific magnetic resonance contrast enhancement

  2008cited by this paper
• Therapeutic and diagnostic applications of dendrimers for cancer treatment.

  2008cited by this paper
• The 2007 WHO Classification of Tumours of the Central Nervous System

  2007cited by this paper
• Glycoconjugated peptide dendrimers-based nanoparticulate system for the delivery of chloroquine phosphate.

  2007cited by this paper
• Dendrimers as potential drug carriers. Part II. Prolonged delivery of ketoprofen by in vitro and in vivo studies.

  2006cited by this paper
• Intravenous Hydrophobic Drug Delivery: A Porous Particle Formulation of Paclitaxel (AI-850)

  2005cited by this paper
• Immobilization of Candida rugosa lipase on chitosan with activation of the hydroxyl groups.

  2004cited by this paper
• Antitumor characteristics of methoxypolyethylene glycol-poly(DL-lactic acid) nanoparticles containing camptothecin.

  2004cited by this paper
• A PEGylated dendritic nanoparticulate carrier of fluorouracil.

  2003cited by this paper
• Modeling and comparison of dissolution profiles.

  2001cited by this paper
• Evaluation of an aqueous injection of ketoprofen.

  1997cited by this paper

• Dendrimer-based therapeutics in neurological disorders: Innovations and clinical prospects.

  2026cites this paper
• Magnetic Mesoporous Nanoparticles as a Versatile Theranostic Tool for Overcoming Limitations in Conventional Drug Delivery and Cancer Treatment

  2026cites this paper
• A modern approach to glioblastoma using temozolomide and nanoparticles carrier drug: a standard care of combination therapy and treatment.

  2025cites this paper
• Hydrogel-based implantable system for local delivery of temozolomide in postsurgical brain cancer therapy

  2025cites this paper
• Emerging trends in chitosan based colloidal drug delivery systems: A translational journey from research to practice.

  2025cites this paper
• Chitosan and Its Derivatives as Nanocarriers for Drug Delivery

  2025cites this paper
• Overview of dendrimers as promising drug delivery systems with insight into anticancer and anti-microbial applications

  2025cites this paper
• Antibody-conjugated polymer nanoparticles for brain cancer

  2025cites this paper
• Nanoparticle-based strategies for overcoming the blood-brain barrier in CNS disorders and brain cancer: precision diagnostics and therapeutics for Alzheimer's, Parkinson's, multiple sclerosis, and glioblastoma.

  2025cites this paper
• Nanoparticle-Based Approaches in the Diagnosis and Treatment of Brain Tumors

  2024cites this paper
• Overcoming the Blood–Brain Barrier: Multifunctional Nanomaterial‐Based Strategies for Targeted Drug Delivery in Neurological Disorders

  2024cites this paper
• Current Non-Metal Nanoparticle-Based Therapeutic Approaches for Glioblastoma Treatment

  2024cites this paper
• Brain gliomas: Diagnostic and therapeutic issues and the prospects of drug-targeted Nano-delivery technology.

  2024cites this paper
• Development and characterization of temozolomide-PAMAM-siRNA dendriplexes for the effective management of glioblastoma multiforme

  2024cites this paper
• Therapeutically targeting the unique disease landscape of pediatric high-grade gliomas

  2024cites this paper
• Application of nanoformulations as a strategy to optimize chemotherapeutic treatment of glioblastoma: a systematic review

  2024cites this paper
• Advanced Targeted Drug Delivery of Bioactive Agents Fortified with Graft Chitosan in Management of Cancer: A Review.

  2024cites this paper
• Glioblastoma Therapy: Past, Present and Future

  2024cites this paper
• Blood-brain barrier-crossing dendrimers for glioma theranostics.

  2024cites this paper
• Chitosan-coated magnetic graphene oxide for targeted delivery of doxorubicin as a nanomedicine approach to treat glioblastoma.

  2024cites this paper
• Nose-to-Brain Delivery of Biomimetic Nanoparticles for Glioblastoma Targeted Therapy

  2024cites this paper
• Carbohydrate polymer-driven nanoparticle synthesis and functionalization in the brain tumor therapy: A review.

  2024cites this paper
• Exploring chitosan nanoparticles for enhanced therapy in neurological disorders: a comprehensive review

  2024influential citation
• Dendrimer Technology in Glioma: Functional Design and Potential Applications

  2023cites this paper
• Indocyanine green-/TLR7 agonist-constructed thermosensitive liposome for low-temperature PTT induced synergistic immunotherapy of colorectal cancer

  2023cites this paper
• Dendrimer: An update on recent developments and future opportunities for the brain tumors diagnosis and treatment

  2023cites this paper
• Biomimetic Construction of Artificial Selenoenzymes

  2023cites this paper
• Application of polymer materials in targeting glioma.

  2023cites this paper
• Advancements in the Application of Nanomedicine in Alzheimer’s Disease: A Therapeutic Perspective

  2023cites this paper
• Strategies increasing the effectiveness of temozolomide at various levels of anti-GBL therapy.

  2023cites this paper
• Recent update on pharmacokinetics and drug metabolism in CNS-based drug discovery.

  2023cites this paper
• Current advances in temozolomide encapsulation for the enhancement of glioblastoma treatment

  2023cites this paper
• Advancement in Solubilization Approaches: A Step towards Bioavailability Enhancement of Poorly Soluble Drugs

  2023cites this paper
• Advanced biomaterials for human glioblastoma multiforme (GBM) drug delivery.

  2023cites this paper
• Polymeric and small molecule-conjugates of temozolomide as improved therapeutic agents for glioblastoma multiforme.

  2022cites this paper
• Role of Nanotechnology and Their Perspectives in the Treatment of Kidney Diseases

  2022cites this paper
• Thermodynamic Solubility Profile of Temozolomide in Different Commonly Used Pharmaceutical Solvents

  2022cites this paper
• Crossing the Blood-Brain Barrier: Advances in Nanoparticle Technology for Drug Delivery in Neuro-Oncology

  2022cites this paper
• Surface Engineered Dendrimers: A Potential Nanocarrier for the Effective Management of Glioblastoma Multiforme.

  2022cites this paper
• Benefits and limitations of nanomedicine treatment of brain cancers and age-dependent neurodegenerative disorders.

  2022cites this paper
• Dendrimer-based drug delivery systems: history, challenges, and latest developments

  2022cites this paper
• Application of therapeutic nanoplatforms as a potential candidate for the treatment of CNS disorders: Challenges and Possibilities.

  2022cites this paper
• Progress in research and development of temozolomide brain-targeted preparations: a review

  2022cites this paper
• Plant extract delivery and antibacterial properties of nano bacterial cellulose in the presence of dendrimer, chitosan, and herbal materials

  2022cites this paper
• A Review on Increasing the Targeting of PAMAM as Carriers in Glioma Therapy

  2022cites this paper
• Smart Nanoformulations for Brain Cancer Theranostics: Challenges and Promises

  2022cites this paper
• Exotic nuclear spin behavior in dendritic macromolecules.

  2021cites this paper
• Dendrimers in tissue engineering

  2021cites this paper
• DENDRIMERS IN ANTICANCER TARGETED DRUG DELIVERY: ACCOMPLISHMENTS, CHALLENGES AND DIRECTIONS FOR FUTURE

  2021cites this paper
• Development and optimization of paclitaxel loaded Eudragit/PLGA nanoparticles by simplex lattice mixture design: Exploration of improved hemocompatibility and in vivo kinetics.

  2021cites this paper
• Nanoparticles for Cancer Therapy

  2021cites this paper
• ДЕНДРИМЕРЫ В ТАРГЕТНОЙ ДОСТАВКЕ ПРОТИВООПУХОЛЕВЫХ ПРЕПАРАТОВ: ДОСТИЖЕНИЯ, ПРОБЛЕМЫ И ПЕРСПЕКТИВЫ ДАЛЬНЕЙШИХ ИССЛЕДОВАНИЙ

  2021cites this paper
• Polymeric magnetic nanoparticles: a multitargeting approach for brain tumour therapy and imaging

  2021cites this paper
• Advances in Chitosan-Based Nanoparticles for Drug Delivery

  2021cites this paper
• Nanotechnology-based drug delivery for central nervous system disorders.

  2021cites this paper
• Temozolomide nano enabled medicine: promises made by the nanocarriers in glioblastoma therapy.

  2021cites this paper
• Chitin-based nanomaterials

  2021cites this paper
• Dendrimers: Properties and Applications in Biomedical Field

  2021cites this paper
• Nanocarriers as Potential Targeted Drug Delivery for Cancer Therapy

  2020cites this paper
• Folate-modified Graphene Oxide as the Drug Delivery System to Load Temozolomide.

  2020cites this paper
• Dendrimers: Amazing Platforms for Bioactive Molecule Delivery Systems

  2020cites this paper
• Nanocargos: A Burgeoning Quest in Cancer Management

  2020cites this paper
• Green nanomedicine: the path to the next generation of nanomaterials for diagnosing brain tumors and therapeutics?

  2020cites this paper
• The effects of chitosan-based materials on glioma: Recent advances in its applications for diagnosis and treatment.

  2020cites this paper
• A Streamlined Study on Chitosan-Zinc Oxide Nanomicelle Properties to Mitigate a Drug-Resistant Biofilm Protection Mechanism

  2020cites this paper
• Molecular Targets and Nanoparticulate Systems Designed for the Improved Therapeutic Intervention in Glioblastoma Multiforme

  2020cites this paper
• Synthesis of biopolymer coated functionalized superparamagnetic iron oxide nanoparticles for the pH-sensitive delivery of anti-cancer drugs epirubicin and temozolomide

  2020cites this paper
• Thermosensitive magnetic nanoparticles exposed to alternating magnetic field and heat-mediated chemotherapy for an effective dual therapy in rat Glioma model.

  2020cites this paper
• Targeting Cancer using Curcumin Encapsulated Vesicular Drug Delivery Systems.

  2020cites this paper
• Chitosan-Based Non-viral Gene and Drug Delivery Systems for Brain Cancer

  2020cites this paper
• Designing Biodegradable Wafers Based on Poly(L-lactide-co-glycolide) and Poly(glycolide-co-ε-caprolactone) for the Prolonged and Local Release of Idarubicin for the Therapy of Glioblastoma Multiforme

  2020cites this paper
• Dendrimers for anticancer drug delivery

  2020cites this paper
• Dapivirine Bioadhesive Vaginal Tablets Based on Natural Polymers for the Prevention of Sexual Transmission of HIV

  2019cites this paper
• An Artificial Intelligent Signal Amplification System for in vivo Detection of miRNA

  2019cites this paper
• Pharmacokinetic studies of nanoparticles as a delivery system for conventional drugs and herb-derived compounds for cancer therapy: a systematic review

  2019cites this paper
• Dendrimer Donepezil Conjugates for Improved Brain Delivery and Better in Vivo Pharmacokinetics

  2019cites this paper
• Nuclear singlet multimers (NUSIMERs) with long-lived singlet states

  2018cites this paper